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ABSTRACT 
BACKGROUND 
Parenteral nutrition (PN) is a complicated therapy in which having specially trained clinicians can provide 
benefit, but it can be difficult to provide this level of expertise to all patients requiring PN. Creation of a 
virtual nutrition support team (NST) model allows patients across multiple hospitals to receive care from 
NST clinicians using remote conferencing technology on a daily basis. This study reviewed retrospective 
data from before and after implementation of the virtual model to assess quality indicators. 
METHODS 
The NST was developed including a team of dietitians and pharmacists with a physician medical director. 
Practice guidelines were developed to provide consistent methods for ordering and monitoring patients 
receiving PN. Patient charts in both the preintervention and postintervention groups were reviewed for 
indication for PN, duration of therapy, blood glucose levels, and demographic data. 
RESULTS 
A greater proportion of patients in the postintervention period had appropriate orders (97.2%) 
compared with patients in the preintervention period (58.9%) (P  < 0.001). A greater proportion of 
patients in the postintervention period had blood glucose levels within the range 65–180 mg/dL (83.5%) 
compared with patients in the preintervention period (62.2%) (P <  0.001). 
CONCLUSION 
A virtual team model was applied to remotely manage patients receiving PN in a large healthcare 
system. This resulted in optimized care of patients by reducing inappropriately prescribed therapy and 
improving blood glucose control. 
Keywords: nutrition support, nutrition support team, parenteral nutrition, telemedicine, 
videoconferencing. 
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BACKGROUND 
Parenteral nutrition (PN) is a specialized form of nutrition support. The complications 
associated with the administration of PN can be classified as mechanical, infectious, 
metabolic, and nutritional.1, 2 The Institute for Safe Medication Practices has given PN 
preparations the status of a high‐alert medication because of increased risk of harm if 
used in error.3 Because of the complexity of PN and associated complications, a high 
level of knowledge and expertise is recommended in the management of these 
patients.4 Physicians receive minimal training and experience in the management of PN 
in standard education.5, 6 The American Society for Parenteral and Enteral Nutrition 
(ASPEN) recommended in 2010 Standards for Nutrition Support that patients receiving 
PN have a nutrition support team (NST) managing the care of the patient.7 An NST is 
made up of clinicians with specialty training in nutrition and can include physicians, 
dietitians, pharmacists, and nurses.8 The multidisciplinary team approach has been 
supported for its ability to assess a patient's nutrition status, prescribe the appropriate 
macronutrients and micronutrients, and decrease the incidence of metabolic 
complications through regular monitoring.8, 9 PN is a more expensive form of nutrition 
support compared with enteral nutrition (EN), and the multidisciplinary NST can assess 
for the appropriateness of PN and the timely transition to enteral or oral nutrition when 
indicated, resulting in cost savings.4, 10-12 
Despite the demonstrated benefits associated with an NST, it can be difficult for a small 
institution to have the resources available for this service. The volume of patients 
receiving PN may be too low to rationalize specialized training by clinicians. Even at a 
larger institution, there are challenges in maintaining clinician competency in PN because 
of fluctuations in patient volumes, competing patient care priorities, and planned clinician 
absence. Using a virtual NST to care for patients at multiple sites addresses both of these 
concerns by allowing sites with smaller PN volumes to share resources with larger sites 
and justifies the time required for clinicians to maintain specialized training in nutrition 
support. 
Our system of care sites includes 10 hospitals in the Midwestern United States. Hospitals 
range from 25 beds to 1059 beds. The hospitals included in the evaluation are shown in 
 
 
Table 1. Historically, PN ordering and practices varied at each site. Some sites had a 
nutrition support clinician evaluating patients daily and others only 5 days per week. Most 
adult patients had new orders placed only for a change in formula. In some sites, glucose 
control was managed by a nutrition support clinician, but at other sites, the primary team 
managed blood glucose. 
Table 1. System Hospitals Descriptionsa 
Hospital Hospital Type Registered 
Beds 
Pre‐Implementation PN Orders Generally 
Recommended By 
1 Community 
teaching 
262 Unit dietitian 
2 Community 107 Unit dietitian/pharmacist 
3 Community 152 Unit dietitian 
4 Level 1 trauma 
center 
636 Nutrition support pharmacist 
5 Tertiary care, 
teaching 
1059 Unit dietitian 
 
• a There are 10 hospitals in the system, but only these 5 were included in the 
evaluation.PN, parenteral nutrition. 
With the institution of a new electronic health record (EHR), an opportunity for 
standardization was created. It was proposed that patients requiring PN could be 
managed virtually for all care sites by a small group of clinicians, allowing a higher level 
of expertise in nutrition support. By implementing a virtual NST, we expected to 
standardize the care and monitoring of patients receiving PN, including daily review in 
accordance with ASPEN recommendations.7, 13 It was hypothesized that this 
standardized approach would reduce the frequency of inappropriate PN orders as well as 
result in improved glucose control for patients receiving PN. 
 
 
METHODS 
IMPLEMENTATION OF THE VIRTUAL NST 
In light of the identified system‐wide gaps in PN ordering and monitoring, beginning in 
2015, a virtual NST model was proposed, developed, and implemented across hospitals. 
The system‐wide transition to a new EHR platform facilitated the coordinated EHR build 
and launch of this virtual model across all hospitals. The service was socialized and 
deployed systematically upon each site's go‐live on the new EHR platform over a period 
of 9 months. This allowed the virtual team to make adjustments to manage the workflow 
and increasing volumes over the 9‐month rolling go‐live. At the time of the 
postintervention evaluation, 5 sites were included in the data. 
First, the team identified a multidisciplinary team of registered dietitians and pharmacists 
with a physician medical director. Competency was assessed by using ASPEN education 
module completion and case studies evaluated by the NST medical director for all team 
members, using board‐certified clinicians as the core of the team. 
Second, to standardize care within the team, practice guidelines were developed to 
provide clinicians with consistent methods for carrying out patient care activities related 
to ordering and providing PN. A Pharmacy and Therapeutics policy was developed to 
dictate that all adult PN orders, including orders for critical care, intermediate care, and 
general medical‐surgical care patients, must be completed by the NST and transmitted 
directly to the pharmacy. Specifically, patients receiving PN are followed daily by a 
specialty trained dietitian and pharmacist who are responsible for metabolic monitoring, 
daily PN prescribing, and assessment of continued clinical indication for the therapy. 
An initial nutrition assessment is performed to determine calorie, protein, and 
micronutrient needs, as well as baseline glycemic control and existing or plan for 
intravenous access. Communication between the virtual NST and unit clinicians was 
maintained to ensure accurate information, assist with physical exam if needed, and 
enhance continuity of care. Regular communication with unit clinicians is essential in a 
virtual model, as bedside documentation can be limited by inaccuracies in reporting intake 
and output, meal consumption, and other charting. Methods included verbal 
 
 
communication, EHR charting, and communication via EHR tools (eg, handoff notes) at 
a frequency of at least daily based on the patient's acuity level and stability on the PN 
formula. Each day, patients with PN orders are assessed for appropriateness for PN 
based on 2016 ASPEN guidelines for critically ill patients and 2010 guidelines and 
ASPEN consensus statement for noncritically ill patients.7, 14, 15 
The NST also manages electrolyte and acid‐base disorders related to PN in consultation 
with the primary team as needed. Glucose management is generally achieved with 
provision of insulin within the PN, although subcutaneous basal and corrective insulin and 
insulin infusions may be comanaged with the medical provider or endocrinologist. Based 
on the ASPEN recommendation to monitor and reorder daily on many patients, the 
decision was made to reorder all PN orders daily.13, 16 A visual representation of the 
process workflow for ordering PN can be seen in Figure 1. NST members monitor for 
continued clinical indication and progress toward transition to EN and/or oral diet while 
maintaining communication with unit clinicians. Remote management is facilitated by a 
daily conference between the NST dietitian and the NST pharmacist to review patients 
and develop individualized care plans. 
 
Figure 1: Virtual NST workflow. NST, nutrition support team; PN, parenteral nutrition. 
 
EVALUATION OF THE VIRTUAL NST 
Three areas were identified prior to implementation to measure satisfactory function of 
the virtual NST: increasing the frequency of patient evaluation to daily on all patients, 
 
 
maintenance of adequate blood glucose control, and restricting PN to patients with 
defined appropriate indication. 
Success of the virtual NST was evaluated by comparing retrospective data for all adult 
patients (≥18 years of age) who were prescribed PN at any of the 5 system hospitals 
during a 6‐month period prior to implementation of the NST (July–December 2013), and 
a 6‐month period after the NST was implemented across all 5 target hospital sites (June–
November 2015). Approval for retrospective chart review was granted by the system's 
Institutional Review Board. Data collected included baseline PN orders across the 
included hospital sites (including total days of PN), blood glucose measurements while 
receiving PN, and indications for parenteral therapy. 
STATISTICAL ANALYSIS 
Demographic characteristics of patients ≥18 years of age who were prescribed PN during 
an inpatient hospital stay across 5 hospitals during the preintervention and 
postintervention periods were described using frequencies and percentages for 
categorical variables and means and SD for continuous variables. Demographic 
characteristics of patients seen during the preintervention and postintervention periods 
were compared using χ2 tests for categorical variables and 2‐sample t‐tests for 
continuous variables. Statistical significance was set at P <  0.05 for all tests. PN orders, 
including total days of PN and indications for PN, were described using frequencies and 
percentages for categorical variables and medians and ranges for continuous variables, 
overall and stratified by preintervention and postintervention. PN orders were compared 
between the preintervention and postintervention periods using χ2 and Wilcoxon rank 
sum tests. The proportion of patients with blood glucose levels within the range 65–
180 mg/dL during the preintervention and postintervention periods was calculated and 
compared using a χ2 test. 
RESULTS 
A total of 420 patients were prescribed PN during the evaluation period (202 prior to 
implementation of the virtual NST and 218 following implementation of the NST). 
 
 
Demographics and clinical characteristics of the patients prescribed PN during the 
preintervention and postintervention intervals are described in Table 2. 
Table 2. Demographics and Clinical Characteristics 
Demographic and 
Clinical 
Characteristics 
Total 
(n = 420) 
Preintervention 
(n = 202) 
Postintervention 
(n = 218) 
P‐
Value 
Female, n (%) 215 (51.2) 107 (53) 108 (49.5) 0.482 
Age, mean (SD) 58.7 
(16.1) 
58.7 (17.1) 58.8 (15.1) 0.941 
Indication for parenteral nutrition, n (%) 
Ileus/small bowel 
obstruction 
157 (37.4) 65 (32.2) 92 (42.2) <0.001 
Other 134 (31.9) 91 (45) 43 (19.7) <0.001 
Gastrointestinal fistula 48 (11.4) 25 (12.4) 23 (10.6) 0.646 
Failed enteral trial 37 (8.8) 7 (3.5) 30 (13.8) <0.001 
Short bowel syndrome 28 (6.7) 7 (3.5) 21 (9.6) 0.017 
Pancreatitis 16 (3.8) 7 (3.5) 9 (4.1) 0.802 
Total days of parenteral 
nutrition, median (range) 
6 (1–49) 6 (1–34) 7 (1–49) 0.589 
 
Overall, the most common indications for parenteral use were ileus/small bowel 
obstruction (37.4%), other (31.9%), and gastrointestinal fistula (11.4%). Comparing 
before and after the creation of the virtual NST, “other” occurred significantly less often in 
the postintervention data, 19.7% compared with 45% (P <  0.001). Indications 
categorized as “other” included cases generally identified as appropriate (patient with 
 
 
bowel in discontinuity, chylothorax, preoperative nutrition support prior to major upper 
gastrointestinal surgery, etc), as well as patients in whom an indication could not be 
identified. The patients in whom the indication could not be identified mostly occurred in 
the preintervention group, in which the chart was being reviewed retrospectively, and 
standardized nutrition support documentation was not utilized at the time. When 
comparing the indication for PN to the ASPEN guidelines for critically ill and hospitalized 
patients, prescribing was categorized as either appropriate or inappropriate.7, 14 If the 
indication was unable to be determined based on documentation, the indication was 
categorized as inappropriate. Some additional examples of patients with indications 
classified as inappropriate include poor oral intake without contraindication to enteral 
feeds and patients with no evidence of preexisting malnutrition started receiving PN prior 
7 days without adequate intake. As shown in Figure 2, a greater proportion of patients in 
the postintervention period had appropriate orders (97.2%) compared with patients in the 
preintervention period (58.9%) (χ2[1]: 92.27; P <  0.001).  
 
Figure 2: Quantity outcomes. 
In comparing glucose management before and after implementing the virtual NST, blood 
glucose levels were based on recommendations from the NICE‐SUGAR trial, endorsed 
by ASPEN.17, 18 Goal blood glucose was defined as 65–180 mg/dL. Standard protocol 
during administration of PN is to have glucose checked at bedside every 4 hours. 
 
 
Understanding that exceptions can occur, maintaining ≥80% of a patient's blood glucose 
readings in the defined range was considered to be acceptable glucose control. As shown 
in Figure 2, a greater proportion of patients in the postintervention period had blood 
glucose levels within the 65–180 mg/dL range (83.5%) compared with patients in the 
preintervention period (62.2%) (χ2[1]: 24.22; P <  0.001). 
DISCUSSION 
The overarching goal of implementing the NST on a virtual level was to provide a higher 
level of expertise to our patients requiring PN without significantly changing resources 
across the system. There was a significant improvement in the number of patients with a 
PN indication that was able to be classified as appropriate after the implementation of the 
virtual NST. Some of this benefit we attributed to the careful evaluation of the NST 
clinician and discussion with the prescribers about possible opportunities for alternate 
nutrition. We do acknowledge that some increase in appropriateness can be attributed to 
poor documentation of indication in the preintervention group, especially as indications 
were classified as inappropriate if unable to be identified. 
There were statistically significant increases in the percentage of indications for 
ileus/small bowel obstruction, failed enteral trial, and short bowel syndrome. Although this 
retrospective chart review cannot definitely determine reasons why the percentage of 
patients categorized as small bowel obstruction/ileus increased in the postintervention 
period, we suspect this is due to more comprehensive documentation by the ordering 
clinician after education from the NST about appropriate indications. An interesting finding 
is the statistically significant increase of the indication for PN being a “failed enteral trial” 
(P <  0.001). Although this retrospective review cannot provide all of the underlying 
reasons for this finding, we postulate that accountability for the initiation and maintenance 
of PN, and daily encouragement to attempt enteral trials, may have prompted the treating 
physician to make more concerted efforts toward EN. Of those who had EN attempted, a 
portion will have succeeded and would have spared the need for PN. Though this 
retrospective review cannot address all of the added benefits of this finding, we presume, 
as has been demonstrated in a substantial body of literature and recommended by 
ASPEN, that EN is superior to PN whenever possible and results in improved outcomes, 
 
 
decreased morbidity, and decreased overall costs.10, 19, 20 As there was a substantial 
increase in the indication of “failed enteral trial,” this shows evidence of a culture change 
in our health system toward increasing compliance in regard to nutrition best practices, 
that is, attempting EN prior to the use of PN. 
By identifying the management of hyperglycemia as the scope of the NST, daily 
evaluation of the blood glucose and adjustment of insulin if needed became more 
standardized than the preintervention patients. The NST established guidelines for 
empiric insulin dosing and for increasing insulin in the PN bag based on amounts of 
corrective insulin received. We chose being within goal at least 80% of the time as the 
goal arbitrarily, acknowledging that excursions from the goal range may occur as we 
titrate the nutrition to goal. Even though the goal was determined without established 
standards defining consistency, the improvement from preintervention to postintervention 
is significant. 
One of our goals of instituting the virtual NST was to standardize care across the system 
and an increase in patients being evaluated by a nutrition support–trained clinician daily 
when compared with PN. Prior to initiation of the virtual model, there was inconsistent 
monitoring and care of the patients. Some sites had a clinician evaluating patients daily 
and others only 5 days per week. Most adult patients had new orders placed only for a 
change in formula. In some sites, glucose control was managed by a nutrition support 
clinician, but at other sites, the primary team managed blood glucose. Following the 
institution of the virtual NST, every patient receiving PN at all sites was evaluated daily 
by a nutrition support dietitian and a pharmacist. We were unable to statistically evaluate 
the change in days of coverage because of limited availability of preintervention data in a 
retrospective review. 
The original goal of remaining full‐time equivalent (FTE) neutral was not met, and after 
initiation, there was a net expansion of 1 dietitian FTE and 0.4 pharmacist FTE. Although 
the NST model required increased FTE, the cost may be offset by decreased utilization 
of PN, reduction of errors and complications, and improved care, which has been 
documented in patients managed by an NST.21 Although the cost analysis could not be 
 
 
completed in our retrospective review, we believe this is an important future area of study 
in our increasingly value‐based healthcare system. 
An added benefit of the virtual NST has been management of many medication shortages 
involving PN ingredients. The small number of clinicians allows easier dissemination and 
notification of shortages, updates to supply, and shortage management strategies. As all 
PN orders were written by the NST clinicians, it was also easier to maintain compliance 
with shortage management strategies. 
Our work demonstrates the effectiveness of a virtual NST to provide superior level 
expertise to patients throughout a hospital system by improving outcomes, such as 
appropriately indicated and monitored PN administration and improved blood glucose 
levels, known to be associated with improved overall outcomes in hospitalized 
patients.22 This model allows an increased level of knowledge in the clinicians managing 
the PN, both by increasing the number of patients managed each month by the clinicians 
and reducing the number of clinicians responsible for managing PN. This also allows a 
smaller institution that may not be able to justify a certified nutrition support clinician to 
pair with other sites so that all patients receive a higher level of care. 
Our next steps include expanding the quality assurance metrics we collect, further 
evaluating PN that is received for 5 days or less, and quantifying cost savings from 
decreasing inappropriate prescribing of PN. The latter could help justify the increase in 
FTE. 
We recognize several limitations to our study. Although the virtual NST model was found 
to be an efficient and useful method for our mature 10‐hospital system, the model may 
not be easily translatable to other systems that are either much larger or much smaller 
than the one we describe. However, the opportunity may exist for smaller entities to team 
up and centralize nutrition support expertise to improve care with limited expansion of 
resources. As with all retrospective studies, we relied heavily on the documentation 
provided in the daily progress notes and bedside documentation, which can sometimes 
be lacking or inadequate. At the time of data collection, we did not include an assessment 
on the acuity of the patients, as some patients were not in critical care and we were unable 
to calculate an Acute Physiologic Assessment and Chronic Health Evaluation or Charlson 
 
 
Comorbidity Index score to assess this. We would note that the service offerings within 
our hospitals (trauma, surgery, medical intensive care, etc.) did not change from the 
preintervention to the postintervention period. 
In conclusion, a virtual team model was applied to remotely manage patients receiving 
PN in a large healthcare system. This resulted in optimized care of patients by reducing 
inappropriately prescribed therapy and improving blood glucose control. 
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